ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Adma Biologics (ADMA) Technical (Analysis) Reports Adma Biologics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Adma Biologics (ADMA)

Technical Analysis Report for NASDAQ stock ADMA Adma Biologics. Dated: 21 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ADMA Adma Biologics then click here. or read Experts views on Adma Biologics or Forecast & share price targets of Adma Biologics

Adma Biologics Opened at 9.77 and Closed at: 9.84, which is 0.81% of previous session's close. It moved within a range of 9.68 and 9.95
The session was a Bullish session with an average volume of 1477000, which is -48.44% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.

Support for tomorrow is 9.76 and resistance for tomorrow is 10.03
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 9.7, 9.55 resistance for tomorrow's hourly charts is 9.97, 10.09

10 Day SMA for Adma Biologics (ADMA) is 9.69 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Adma Biologics (ADMA) is 9.34 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Adma Biologics (ADMA) is 8.94 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 9.11 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Adma Biologics is 12.88 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Adma Biologics is at 9.34 and 200 DMA is at 12.88, while 50 DMA and 100 DMA are at 8.94 and 9.11 respectively

Adma Biologics (ADMA) moving average of 20 SMA is at 9.34 and 20 EMA is at 9.42

Adma Biologics (ADMA) moving average of 50 SMA is at 8.94 and 50 EMA is at 9.22

Adma Biologics (ADMA) moving average of 100 SMA is at 9.11 and 100 EMA is at 9.96

Adma Biologics (ADMA) moving average of 200 SMA is at 12.88 and 200 EMA is at 11.88

Adma Biologics has performed better than Bio Techne in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Sutro Biopharma in short term. Holding Adma Biologics could be a better choice for now!

Solid Biosciences has performed better than Adma Biologics in short term. You could have earned much better returns by investing in Solid Biosciences, about 1.83% more returns!

Adma Biologics has performed better than Puma Biotechnology in short term. Holding Adma Biologics could be a better choice for now!

Omeros Corporation has performed better than Adma Biologics in short term. You could have earned much better returns by investing in Omeros Corporation, about 53.89% more returns!

Adma Biologics has performed better than Novocure in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Neurotrope Inc in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than National Research in short term. Holding Adma Biologics could be a better choice for now!

Mesoblast has performed better than Adma Biologics in short term. You could have earned much better returns by investing in Mesoblast, about 0.64% more returns!

Adma Biologics has performed better than Madrigal Pharmaceuticals in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Moleculin Biotech in short term. Holding Adma Biologics could be a better choice for now!

Achieve Life has performed better than Adma Biologics in short term. You could have earned much better returns by investing in Achieve Life, about 13.25% more returns!

Argenx Se has performed better than Adma Biologics in short term. You could have earned much better returns by investing in Argenx Se, about 0.94% more returns!

Adma Biologics has performed better than Beyondspring Inc in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Celcuity Inc in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Enanta Pharmaceuticals in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Icon Plc in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Iradimed Corporation in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics Technical analysis of indicators

Price action analysis of Adma Biologics (ADMA) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Adma Biologics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.

MACD generated a BUY signal for Adma Biologics in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Adma Biologics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a SELL signal for Adma Biologics in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Adma Biologics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 9.72 and Adma Biologics ADMA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Adma Biologics ADMA stock. Volume based technical analysis of Adma Biologics ADMA stock is negative.

Adma Biologics Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ADMA Adma Biologics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ADMA Experts View which covers a lot of information including buying and selling signals

ADMA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Adma Biologics or View Candle Stick Charts here

Chart Adma Biologics (ADMA)  Technical (Analysis) Reports Adma Biologics [

Videos related to: Adma Biologics (ADMA) Technical (Analysis) Reports Adma Biologics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Adma Biologics (ADMA)  Technical (Analysis) Reports Adma Biologics [

 

Back to top